7 completed, 1 not yet recruiting, 1 terminated, 1 unknown. 7 Phase 1, 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 7 |
| Phase 2 | 2 | Not yet recruiting 1, Terminated 1 |
| Not applicable | 1 | Unknown 1 |
Follow Pharmacokinetic Study: new trials by email Literature Review of Pharmacokinetic Study trials Research Report on Pharmacokinetic Study
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer Enzalutamide Dose Escalation, Standard of Care - Prostate Cancer Patients, Elderly Patients | Phase 2 | Not yet recruiting | Sunnybrook Health Sciences Centre | 26 | 2026-04-01 | 2026-04-06 |
| An Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS) AGA2118 - Healthy Participants, Pharmacokinetic Study | Phase 1 | Completed | Angitia Incorporated Limited | 28 | 2026-01-05 | 2026-09-10 |
| Study the Effect of Omeprazole on AB-106 Pharmacokinetics Multiple administration of omeprazole Single administration of AB-106 - Pharmacokinetic Study | Phase 1 | Completed | Nuvation Bio Inc. | 24 | 2022-11-02 | 2024-11-21 |
| Pharmacokinetic Study for IV Allopregnanolone PK-1 Good Manufacturing Practices (GMP) allopregnanolone (Allo) with Dexolve in 0.9% saline for infusion manufactured by the University of California, Davis, PK-2 GMP allopregnanolone (Allo) with Dexolve in 0.9% saline for infusion manufactured by the University of California, Davis. - Pharmacokinetic Study, Post Traumatic Stress Disorder | Phase 2 | Terminated | Boston University | 11 | 2022-03-04 | 2026-06-02 |
| A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects TQ-B3101 - Pharmacokinetic Study | Phase 1 | Completed | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 16 | 2021-05-20 | 2022-01-21 |
| Toxicokinetic Study of Dichlorobisphenol A After an Oral or Dermal Single Dose in Healthy Volunteer. Administration of d12-Cl2BPA - Pharmacokinetic Study | Not applicable | Unknown | Poitiers University Hospital | 12 | 2021-03-01 | 2021-04-05 |
| A Study of Ralinepag in Healthy Chinese Adult Subjects Ralinepag - Healthy Volunteer, Pharmacokinetic Study | Phase 1 | Completed | Everstar Medicines (Shanghai) Limited | 15 | 2020-10-09 | 2024-02-01 |
| Two Way Cross Over BE Fasting Pilot Study of Ropinirole Hydrochloride CR 2mg Tablets Test Product (Ropinirole), Reference Product (REQUIP ) - Pharmacokinetic Study | Phase 1 | Completed | Lupin Ltd. | 12 | 2008-09-01 | 2012-10-23 |
| Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fasting Conditions Ropinirole hydrochloride CR Tablets 2mg - Pharmacokinetic Study | Phase 1 | Completed | Lupin Ltd. | 12 | 2008-09-01 | 2012-10-30 |
| Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fed Conditions Ropinirole hydrochloride CR 2mg Tablets - Pharmacokinetic Study | Phase 1 | Completed | Lupin Ltd. | 12 | 2008-09-01 | 2012-10-26 |
Prostatic Neoplasms (1) · Stress Disorders, Post-Traumatic (1)
Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Male Urogenital Diseases (1) · Mental Disorders (1) · Neoplasms (1) · Neoplasms by Site (1) · Prostatic Diseases (1) · Stress Disorders, Traumatic (1) · Trauma and Stressor Related Disorders (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1)
ropinirole (3) · Pregnanolone (1) · SBE4-beta-cyclodextrin (1) · Sodium Chloride (1) · Standard of Care (1) · ralinepag (1)
Lupin Ltd. (3) · Angitia Incorporated Limited (1) · Boston University (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Everstar Medicines (Shanghai) Limited (1) · Nuvation Bio Inc. (1) · Poitiers University Hospital (1) · Sunnybrook Health Sciences Centre (1)
China (3) · India (3) · United States (2) · Canada (1) · France (1)
Satyanarayana V, M.Pharma., Ph.D (3) · Ann M Rasmusson, MD (1) · Daniel Khalaf, MD (1) · Haiyan Li (1)
R01MH122867 (1)